Trial site
Woodland International Research Group
- 12running trials
- 5closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Schizophrenia5 trials
- Bipolar disorder4 trials
- Depression4 trials
- Phase
- Phase 313 trials
- Phase 23 trials
- Phase 11 trial
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed5 trials
- Lead sponsor
- Xenon Pharmaceuticals Inc.4 trials
- Eli Lilly and Company3 trials
- Bristol-Myers Squibb2 trials
- LB Pharmaceuticals Inc.2 trials
- Otsuka Pharmaceutical Development & Commercialization, Inc.2 trials
- and 4 more
Running trials
Recruiting
Recruiting
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Active, not recruiting
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
An Open-Label Study of Azetukalner in Major Depressive Disorder
Active, not recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Recruiting
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bipolar disorder2 recruiting
- Schizophrenia2 recruiting
Closed trials
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Completed
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026